UB-TT170

N/A

Report date: 2025/03/11 16:31:11

Base Information

Drug NameUB-TT170
Drug Alias NameUB-TT170UB-TT-170UB_TT170UB_TT-170
ClassificationSmall molecules
Mechanisms of ActionT lymphocytes modulatorsImmunologic cytotoxicityFolate receptor alpha modulators +[4] 
TargetsFolate receptor alphaFolate receptor beta
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUmoja BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUmoja BioPharma Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A